Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

Zucara Therapeutics Inc., ("Zucara" or the "Company") a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent ...

and packaging of Sanofi’s SoloStar insulin pens and advanced insulin products. This strategic partnership reinforces our commitment to reduce the burden of importing medicines, increase access to high ...

Medical experts have decried the skyrocketing cost and unavailability of diabetes medications in the country. This was even ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with ...

In a report released today, Peter Welford from Jefferies maintained a Sell rating on Novo Nordisk (0QIU – Research Report), with a price ...

The Global Health Exhibition 2024 witnessed today, Oct. 22, the signing of a final agreement to localize the production of some insulin products, in partnership with National Unified Procurement Co.

Nearly one-third of those patients were paying $35 or far more per month in 2019, according to the latest available data from ...

A Sanofi official told lawmakers the company ... patients and have proven more lucrative for manufacturers than insulin products. Over the past five years, GLP-1s have surpassed insulin as the ...

The Act pressured pharmaceutical companies to lower drug prices: this year, Novo Nordisk and Sanofi lowered the cost of their ...

Levemir (insulin detemir) has a shorter duration of action than other long-acting basal insulins like Sanofi's Lantus (insulin ... the cost of insulin products in the US marketplace – agreed ...

Janel Wright had just days left in her insulin supply in early January when a pharmacist told her there was none of the drug left to fill her prescription. Her neighborhood Fred Meyer pharmacy in ...